Top

Esophagus

Published in:

Open Access 01-10-2017 | Special Article

Descriptive Rules for Achalasia of the Esophagus, June 2012: 4th Edition

Author: Japan Esophageal Society

Published in: Esophagus | Issue 4/2017

Excerpt

Review Committee for Descriptive Rules for Achalasia of the Esophagus …

Iwakiri K, Hoshihara Y, Kawami N, et al. The appearance of rosette-like esophageal folds(“esophageal rosette”)in the lower esophagus after a deep inspiration is a characteristic endoscopic finding of primary achalasia. J Gastroenterol. 2010;45(4):422–5.CrossRefPubMed

Camacho-Lobato L, Katz PO, Eveland J, et al. Vigorous achalasia: original description requires minor change. J Clin Gastroenterol. 2001;33(5):375–7.CrossRefPubMed

Hongo M. The effects of calcium-antagonists on lower esophageal sphincter pressure-the possibility of application of nifedipine to achalasia. J Jpn Soc Gastroenterol. 1982;79(10):1883–91.

Becker BS, Burakoff R. The effect of verapamil on the lower esophageal sphincter pressure in normal subjects and in achalasia. Am J Gastroenterol. 1983;78(12):773–5.PubMed

Wong RK, Maydonovitch C, Garcia JE, et al. The effect of terbutaline sulfate, nitroglycerin, and aminophylline on lower esophageal sphincter pressure and radionuclide esophageal emptying in patients with achalasia. J Clin Gastroenterol. 1987;9(4):386–9.CrossRefPubMed

Coccia G, Borttolotti M, Michetti P, et al. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia. Gut. 1991;32(6):604–6.CrossRefPubMedPubMedCentral

Short TP, Thomas E. An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm. Drug. 1992;43(2):177–84.CrossRef

Harasawa S. Manual for treatment of chronic diseases. Achalasia. Clinic All-Round. 1997;46:1059–62.

Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut. 2002;50(6):758–64.CrossRefPubMedPubMedCentral

10.

Kaufman JA, Oelschlager BK. Treatment of achalasia. Curr Treat Opinions Gastroenterol. 2005;8(1):59–69.CrossRef

11.

Tanaka Y, Iwakiri K, Kawami N, et al. Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia. J Gastroenterol. 2010;45(2):153–8.CrossRefPubMed

12.

Boeckxstaens GE, Annese V, des Varannes SB, et al. European Achalasia Trial Investigators. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16.CrossRefPubMed

13.

Richter JE, Boeckxstaens GE. Management of achalasia: surgery or pneumatic dilation. Gut. 2011;60(6):869–76.CrossRefPubMed

14.

Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann Surg. 2004;239(3):364–70.CrossRefPubMedPubMedCentral

15.

Mikaeli J, Yaghoobi M, Montazeri G, et al. Efficacy of botulinum toxin injection before pneumatic dilatation in patients with idiopathic achalasia. Dis Esophagus. 2004;17(3):213–7.CrossRefPubMed

16.

Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy(POEM)for esophageal achalasia. Endoscopy. 2010;42(4):265–71.CrossRefPubMed

17.

Makuuchi H, Mitomi T, Sasaki T, et al. Diagnosis and treatment for esophageal achalasia. The Japanese. J Thorac Cardiovasc Surg. 1988;36(5):737–9.

18.

Mitomi T, Makuuchi H. Functional disorders. Surgery for esophagus. Shin Gekagaku Taikei 21, Nakayama-shoten, Tokyo, pp 353–96;1988.

19.

Kostic S, Kjellin A, Ruth M, et al. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. World J Surg. 2007;31(3):470–8.CrossRefPubMed

20.

Lopushinsky SR, Urbach DR. Pneumatic dilatation and surgical myotomy for achalasia. JAMA. 2006;296(18):2227–33.CrossRefPubMed

21.

Palanivelu C, Maheshkumar GS, Jani K, et al. Minimally invasive management of achalasia cardia: results from a single center study. JSLS. 2007;11(3):350–7.PubMedPubMedCentral

22.

Wang L, Li YM, Li L. Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci. 2009;54(11):2303–11.CrossRefPubMed

23.

Zaninotto G, Costantini M, Rizzetto C, et al. Four hundred laparoscopic myotmies for esophageal achalasia: a single centre experience. Ann Surg. 2008;248(6):986–93.CrossRefPubMed

24.

Jeansonne LO, White BC, Pilger KE, et al. Ten-year follow-up of laparoscopic Heller myotomy for achalasia shows durability. Surg Endosc. 2007;21(9):1498–502.CrossRefPubMed

25.

Esophageal motility testing made easy. Bremner CG, DeMeester TR, Bremner RM, Mason RJ, eds. Quality Medical Publishing, ST. Louis, Missouri, 2001.

26.

Kusano M, Maeda M, Shimoyama Y, et al. Esophageal motor function in nonachalasia motility disorders. J Jpn Soc Gastroenterol. 2003;100(9):1095–105.

27.

Kashiwagi H, Omura N. Each argument 1. Benign diseases 2. Function and abnormal structure. Shokudogeka up-to-date, Kuwano H eds, Chugai Medical co, Tokyo, p 40–55;2010.

28.

Clouse RE, Staiano A. Contraction abnormalities of the esophageal body in patients referred for manometry. Dig Dis Sci. 1983;28(9):784–91.CrossRefPubMed

29.

Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. 1988;94(1):73–80.CrossRefPubMed

30.

Leite LP, Johnston BT, Barrett J, et al. Ineffective esophageal motility(IEM):the primary finding in patients with non-specific esophageal motility disorder. Dig Dis Sci. 1997;42(9):1859–65.CrossRefPubMed

Title: Descriptive Rules for Achalasia of the Esophagus, June 2012: 4th Edition
Author: Japan Esophageal Society
Publication date: 01-10-2017
Publisher: Springer Japan
Published in: Esophagus / Issue 4/2017
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI: https://doi.org/10.1007/s10388-017-0589-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Descriptive Rules for Achalasia of the Esophagus, June 2012: 4th Edition

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Poor inter-observer agreement on the endoscopic diagnosis of eosinophilic esophagitis among Japanese endoscopists

Prospective pilot study of adoptive immunotherapy with autologous αβT cells for five cases of advanced and/or recurrent esophageal squamous cell carcinoma

Preoperative patient-related factors associated with prognosis after esophagectomy for esophageal cancer

Decreased risk of esophageal cancer owing to cigarette and alcohol cessation in smokers and drinkers: a systematic review and meta-analysis

The importance of the concept and histological criteria of “intraepithelial squamous cell carcinoma” of the esophagus: in comparison between Western and Japanese criteria

Clinicopathological features and pathological evaluation of preoperative treatment of patients with resectable esophageal carcinosarcoma

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page